Martha Linet Selected Research

Martha Linet Research Topics

8	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2019
6	Neoplasms (Cancer) 01/2022 - 12/2015
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2008 - 01/2006
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Neural Tube Defects (Exencephaly) 05/2018
1	Neoplasm Metastasis (Metastasis) 12/2015
1	Thyroid Neoplasms (Thyroid Cancer) 12/2015
1	Glioma (Gliomas) 10/2011
1	Sunburn 11/2007
1	Acne Vulgaris 11/2007
1	Basal Cell Carcinoma (Rodent Ulcer) 11/2007
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2007
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2006
1	Genomic Instability 10/2006
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2006
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2005
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2005

6	Hormones (Hormone)IBA 01/2022 - 10/2011
4	Estrogen ReceptorsIBA 01/2023 - 01/2019
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2022 - 01/2021
2	Benzene (Benzole)IBA 10/2006 - 10/2005
1	mahuang-tangIBA 01/2022
1	human ERBB2 proteinIBA 01/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Progesterone FDA LinkGeneric 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2018
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2015
1	Antineoplastic Agents (Antineoplastics)IBA 12/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2015
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2015
1	Oral ContraceptivesIBA 10/2011
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 10/2006
1	CytokinesIBA 01/2006
1	Interleukin-10 (Interleukin 10)IBA 01/2006
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2005

3	Therapeutics 01/2022 - 10/2011
1	Drug Therapy (Chemotherapy) 01/2021
1	Blood Transfusion (Blood Transfusions) 08/2008
1	Anesthesia 08/2008
1	Radiotherapy 11/2007